Four out of 46 carriers of PVs (8.7%) harbored a PV in RAD51C, RAD51D, and MSH6. RAD51C and RAD51D confer higher risks of ovarian cancer and MSH6, for endometrial, ovarian, and colorectal cancer. Here, MSH6 is linked to ovarian cancer.